Background and Aims : Status asthmaticus is a common cause of morbidity and mortality. The addition of ketamine to the standard treatment regimen of severe asthma has shown to improve outcome and alleviate the need for mechanical ventilation. The purpose of this review is to determine the pulmonary effects of ketamine and to determine whether sufficient evidence exists to support its use for refractory status asthmaticus. Data Source: MEDLINE, EMBASE, Google Scholar, and Cochrane data bases (from their inception to Jan 2012) using key words \"ketamine,\" \"asthma,\" \"bronchospasm,\" \"bronchodilator,\" and \"mechanical ventilation\" were searched to identify the reports on the use of ketamine as a bronchodilator in acute severe asthma or status asthmaticus, and manual review of article bibliographies was done. Relevant databases were searched for the ongoing trials on use of ketamine as a bronchodilator. Outcome measures were analyzed using following clinical questions: Indication, dose and duration of ketamine use, main effects on respiratory mechanics, adverse effects, and mortality. Results: Twenty reports illustrating the use of ketamine as a bronchodilator were identified. In total, 244 patients aged 5 months to 70 years received ketamine for bronchospasm. Twelve case reports, 3 double-blind randomized placebo-controlled trials, 2 prospective observational studies, 2 clinical evaluation study, and 1 retrospective chart review were retrieved. Most of the studies showed improved outcome with use of ketamine in acute severe asthma unresponsive to conventional treatment. Patients who received ketamine improved clinically, had lower oxygen requirements, and obviated the need for invasive ventilation. Mechanically-ventilated patients for severe bronchospasm showed reduction in peak inspiratory pressures, improved gas exchange, dynamic compliance and minute ventilation, and could be weaned off successfully following introduction of ketamine. Conclusion: In various studies, ketamine has been found to be a potential bronchodilator in severe asthma. However, a large prospective clinical trial is warranted before laying down any definitive recommendations on its use in status asthmaticus.
Global Strategy for Asthma Management and Prevention. Available from: http://www.ginasthma.org/pdf/GINA_Pocket_2010a.pdf. [Last accessed on 2011 Jul 20].
Aggarwal AN, Chaudhry K, Chhabra SK, D′Souza GA, Gupta D, Jindal SK, et al. Prevalence and risk factors for bronchial asthma in Indian adults: A multicentre study. Indian J Chest Dis Allied Sci 2006;48:13-22.
Stevenson C. Ketamine: A review. Update in Anaesthesia 2005;20:25-9.
Reich DL, Silvay G. Ketamine: An update on the first twenty-five years of clinical experience. Can J Anaesth 1989;36:186-97.
Vollenweider FX, Leenders KL, Oye I, Hell D, Angst J. Differential psychopathology and patterns of cerebral glucose utilization produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET). Eur Neuropsychopharmacol 1997;7:25-38.
Zeilhofer HU, Swandulla D, Geisslinger G, Brune K. Differential effects of ketamine enantiomer on NMDA receptor currents in cultured neurons. Eur J Pharmacol 1992;213:155-58.
Adams HA, Bauer R, Gebhardt B, Menke W, Baltes- Gotz B. Total IV anesthesia with S-(+)-ketamine in orthopedic geriatric surgery. Endocrine stress reaction, hemodynamics and recovery. Anaesthesist 1994;43:92-100.
Geisslinger G, Hering W, Thomann P, Knoll R, Kamp HD, Brune K. Pharmacokinetics and pharmacodynamics of ketamine enantiomers in surgical patients using a stereoselective analytical method. Br J Anaesth 1993;70:666-71.
White PF, Ham J, Way WL Trevor AJ. Pharmacology of ketamine isomers in surgical patients. Anesthesiology 1980;52:231-9.
Sato T, Hirota K, Matsuki A, Zsigmond EK, Rabito SF. The role of the N-Methyl-D-Aspartic acid receptor in the relaxant effect of ketamine on tracheal smooth muscle. Anesth Analg 1998;87:1383-8.
Zhu MM, Qian YN, Zhu W, Xu YM, Rong HB, Ding ZN, et al. Protective effects of ketamine on allergen-induced airway inflammatory injure and high airway reactivity in asthma: Experiment with rats. Zhonghua Yi Xue Za Zhi 2007;87:1308-13.
Chang Y, Chen TL, Sheu JR, Chen RM. Suppressive effects of ketamine on macrophage functions. Toxicol Appl Pharmacol 2005;204:27-35.
Zhu Meihua, Zhu Minmin, Zhou Qinhai, et al. Effect of aerosolized ketamine inhalation on IL-4 concentration in asthma rat model. J Clin Anaesthesiol 2004-06. Available from: http://en.cnki.com.cn/Article_en/CJFDTOTAL-LCMZ200406017.htm. [Last accessed date 2012 sep].
Hirota K, Sato T, Rabito SF, Zsigmond EK, Matsuki A. Relaxant effect of ketamine and its isomers on histamine-induced contraction of tracheal smooth muscle. Br J Anaesth 1996;76:266-70.
Mathewson HS, Davis TA. Bronchodilator properties of ketamine. Respir Care 1997;42:292-3.
Nehama J, Pass R, Bechtler-Karsch A, Steinberg C, Notterman DA. Continuous ketamine infusion for the treatment of refractory asthma in a mechanically ventilated infant: Case report and review of the pediatric literature. Pediatr Emerg Care 1996;12:294-7.
Pabelick CM, Jones KA, Street K, Lorenz RR, Warner DO. Calcium concentration-dependent mechanisms through which ketamine relaxes canine airway smooth muscle. Anesthesiology 1997;86:1104-11.
Hirota K, Sato T, Rabito SF, Zsigmond EK, Matsuki A. Relaxant effect of ketamine and its isomers on histamine-induced contraction of tracheal smooth muscle. Br J Anesth 1996;76:266-70.
Ebert B, Mikkelsen S, Thorkildsen C, Borgbjerg FM. Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord. Eur J Pharmacol 1997;333:99-104.
Grant IS, Nimmo WS, McNicol LR, Clements JS. Ketamine disposition in children and adults. Br J Anaesth 1983;55:1107-11.
Qureshi FA, Mellis PT, McFadden MA. Efficacy of oral ketamine for providing sedation and analgesia to children requiring laceration repair. Pediatr Emerg Care 1995;11:93-7.
Roelofse JA, Joubert JJ, Swart LC, Stander I, Roelofse PG. An evaluation of the effect of oral ketamine and standard oral premedication in the sedation of paediatric dental patients. J Dent Assoc S Afr 1996;51:197-201.
Bourke DL, MAlit LA, Smith TC. Respiratory interactions of ketamine and morphine. Anesthesiology 1987;66:153-6.
Hamza J, Ecoffey C, Gross JB. Ventilatory response to CO2 following intravenous ketamine in children. Anesthesiology 1989;70:422-25.
Mankikian B, Cantineau JP, Sartene R, Clergue F, Viars P. Ventilatory pattern of chest wall mechanics during ketamine anesthesia in humans. Anesthesiology 1986;65:492-99.
Shulman D, Beardsmore CS, Aronson HB, Godfrey S. The effect of ketamine on the functional residual capacity in young children. Anesthesiology 1985;62:551-56.
Betts EK, Parkin CE. Use of ketamine in an asthmatic child. Anesth Analg 1971;50:420-1.
Corssen G, Gutierrez J, Reves JG, Huber FC Jr. Ketamine in the anesthetic management of asthmatic patients. Anesth Analg Curr Res 1972;51:588-96.
Youssef-Ahmed MZ, Silver P, Nimkoff L, Sagy M. Continuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive Care Med 1996;22:972-6.
Hemmingsen C, Nielsen PK, Odorico J. Ketamine in the treatment of bronchospasm during mechanical ventilation. Am J Emerg Med 1994;12:417-20.
Shlamovitz GZ, Hawthorne T. Intravenous ketamine in a dissociating Dose as a temporizing measure to avoid mechanical ventilation in adult patient with severe asthma exacerbation. J Emerg Med 2008;41:492-4.
Strube PJ, Hallam PL. Ketamine by continuous infusion in status asthmaticus. Anaesthesia 1986;41:1017-9.
Jahangir SM, Islam F, Chowdhury SN, Aziz L, Ghani MA. Ketamine infusion for postoperative analgesia: A prospective cohort study in asthmatics. Bangladesh Med Res Counc Bull 1993;19:21-7.
Achar MN, Achar KN. Efficacy of ketamine infusion in refractory asthma complicated by acute myocardial infarction. Anaesth Intensive Care 1993;21:115-7.
Park GR, Manara AR, Mendel L, Bateman PE. Ketamine infusion. Its use as a sedative, inotrope and bronchodilator in a critically ill patient. Anaesthesia 1987;42:980-3.
Huber FC Jr, Reves JG, Gutierrez J, Corssen G. Ketamine: Its effect on airway resistance in man. South Med J 1972;65:1176-80.
Petrillo TM, Fortenberry JD, Linzer JF, Simon HK. Emergency department use of ketamine in pediatric status asthmaticus. J Asthma 2001;38:657-64.
Heshmati F, Zeinali MB, Noroozinia H, Abbacivash R, Mahoori A. Use of ketamine in severe status asthmaticus in intensive care unit. Iran J Allergy Asthma Immunol 2003;2:175-80.
Howton JC, Rose J, Duffy S, Zoltanski T, Levitt MA. Randomized, double-blind, placebo-controlled trial of intravenous ketamine in acute asthma. Ann Emerg Med 1996;27:170-5.
Allen JY, Macias CG. The efficacy of ketamine in pediatric emergency department patients who present with acute severe asthma. Ann Emerg Med 2005;4:43-50.
Rock MJ, Reyes de la Rocha S, L′Hommedieu CS, Truemper E. Use of ketamine in asthmatic children to treat respiratory failure refractory to conventional therapy. Crit Care Med 1986;14:514-16.
Fisher MM. Ketamine hydrochloride in severe bronchospasm. Anesthesia 1977;32:771-2.
Turnpenny PD, Nash SF. Ketamine in severe acute asthma. Arch Emerg Med 1991;8:291-2.
Hemming A, MacKenzie I, Finfer S. Response to ketamine in status asthmaticus resistant to maximal medical treatment. Thorax 1994;49:90-1.
Galbis-Reig D, Rasansky MA. A case presentation and literature review of successful ketamine administration in a patient with refractory status asthmaticus. Internet J Intern Med 2004;5:31.